Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127949601 | 12794960 | 1 | I | 20160718 | 20160919 | 20160929 | 20160929 | EXP | CN-SA-2016SA175922 | AVENTIS | 69.00 | YR | E | M | Y | 79.00000 | KG | 20160929 | OT | CN | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127949601 | 12794960 | 1 | PS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | Y | 5A827 | 20839 | 75 | MG | TABLET | QD | |||||
127949601 | 12794960 | 2 | SS | BAYASPIRIN | ASPIRIN | 1 | Oral | STRENGTH: 100 MG | Y | BJ28628 | 0 | .1 | G | COATED TABLET | QD | ||||
127949601 | 12794960 | 3 | C | HEPARIN CALCIUM | HEPARIN CALCIUM | 1 | Subcutaneous | 0 | .4 | ML |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127949601 | 12794960 | 1 | Prophylaxis |
127949601 | 12794960 | 2 | Prophylaxis |
127949601 | 12794960 | 3 | Thrombosis prophylaxis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127949601 | 12794960 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127949601 | 12794960 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127949601 | 12794960 | 1 | 20140516 | 20160720 | 0 | |
127949601 | 12794960 | 2 | 20140516 | 20160720 | 0 |